Klivira
Request demo

Optimizing Beovu Prior Authorization for Gastroenterology Workflows

While Beovu (brolucizumab) is primarily indicated for ophthalmologic conditions, managing any drug's prior authorization in a gastroenterology practice demands robust automation. Klivira streamlines the Beovu prior authorization for gastroenterology, ensuring efficiency even for less common requests.

Revenue cycle directors and prior authorization coordinators in gastroenterology face significant burdens from high-volume biologics, procedures, and imaging PAs. Integrating an intelligent automation platform is crucial for navigating diverse payer requirements and reducing administrative overhead, freeing staff to focus on patient care.

Understanding Prior Authorization in Gastroenterology

Gastroenterology practices routinely manage complex prior authorizations for a wide array of treatments, including high-volume biologics for IBD, advanced imaging, and endoscopic procedures. While Beovu is typically prescribed by ophthalmologists, Klivira’s platform offers comprehensive PA automation capabilities that can be applied to any medication or procedure a GI practice might encounter, ensuring consistent and efficient processing.

Key Prior Authorization Categories in GI

  • IBD biologics (e.g., TNF inhibitors, integrin inhibitors, IL-12/23 inhibitors, JAK inhibitors)
  • Hepatitis C direct-acting antivirals
  • Advanced imaging (e.g., MRCP, MR enterography, CT enterography)
  • Endoscopic procedures with specific PA requirements (e.g., capsule endoscopy, ERCP, EUS)
  • Specialty drugs for functional GI disorders

Documentation Requirements for GI Prior Authorizations

Successful prior authorization in gastroenterology hinges on meticulous documentation aligned with clinical guidelines from bodies like ACG, AGA, and AASLD. Klivira's platform is designed to identify and prompt for the specific clinical data points required by payers, whether for a common IBD biologic or an atypical medication like Beovu, streamlining the submission process.

Common Documentation for GI PAs

  • Diagnosis confirmation (endoscopic, imaging, histologic for IBD)
  • Disease severity assessment (e.g., Mayo score for UC, CDAI for Crohn's)
  • Prior conventional-therapy trial documentation
  • TB and hepatitis screening pre-biologic initiation
  • Genotype, fibrosis stage, and prior-treatment history for Hep C DAAs
  • Clinical question and prior imaging history for advanced imaging

Addressing Denial Reasons in Gastroenterology

Denials frequently stem from issues like step therapy non-compliance, biosimilar mandates, or insufficient documentation of disease severity or screening. Klivira's intelligent logic anticipates these common pitfalls, helping practices proactively meet payer requirements and reduce denials across all GI-related prior authorizations, including those with unique profiles like Beovu.

Frequent GI Prior Authorization Denials

  • Step therapy not followed for IBD biologics (e.g., conventional therapy or TNF inhibitor trial required)
  • Biosimilar substitution required over brand-name biologic
  • Disease severity not adequately documented (missing scores or equivalent measures)
  • Gaps in required screening documentation (e.g., TB, hepatitis pre-biologic)
  • Fibrosis-stage documentation gaps for Hep C DAAs
  • Inappropriate-use criteria for advanced imaging (e.g., lack of clinical correlation)

Klivira's Platform for Gastroenterology Prior Authorization

Klivira’s platform integrates seamlessly with major EMRs, automating the submission of X12 278 and ePA requests via NCPDP SCRIPT, Da Vinci PAS, and payer portals. Our solution is built to manage the chronic-treatment ongoing PA burden for IBD biologics, navigate biosimilar policy variability, and accurately classify treatment-naive vs. treatment-experienced patients, ensuring even unusual requests like Beovu prior authorization for gastroenterology are handled with precision.

Frequently asked questions

How does Klivira handle prior authorizations for biologics in gastroenterology?

Klivira automates the entire PA workflow for GI biologics, leveraging ACG/AGA-guideline-aware step therapy logic, EMR medication history for treatment status classification, and periodic re-authorization workflows for chronic treatments. This includes managing medical-vs-pharmacy benefit routing for administration mode changes.

Can Klivira integrate with our EMR for GI prior authorizations?

Yes, Klivira offers robust EMR integration capabilities, including SMART on FHIR, to extract necessary clinical data directly from your system. This eliminates manual data entry, speeds up the process, and ensures accuracy for all GI prior authorization submissions.

What specific GI guidelines does Klivira's logic support?

Klivira's platform incorporates logic informed by major gastroenterology guidelines from bodies such as the ACG, AGA, and AASLD. This ensures that submitted prior authorizations align with current clinical best practices and payer medical necessity criteria for various GI conditions.

How does Klivira manage re-authorizations for chronic GI treatments?

Our platform includes dedicated workflows for periodic re-authorization of chronic GI treatments, such as IBD biologics. It tracks approval expirations, proactively initiates the re-authorization process, and ensures all required updated documentation of disease response is gathered and submitted.

Does Klivira assist with prior authorization for advanced GI imaging?

Yes, Klivira streamlines prior authorization for advanced GI imaging modalities like MRCP, MR enterography, and CT enterography. The platform helps ensure that submissions include the necessary clinical questions, prior imaging history, and conservative-evaluation workup completion as required by payer policies.

If Beovu is primarily for ophthalmology, how does Klivira address its PA in a GI context?

While Beovu is not a standard GI drug, Klivira's platform is designed to handle prior authorizations for any medication. If a GI practice were to submit a PA for Beovu, Klivira would apply its general automation capabilities, integrating with EMRs and payer portals to process the request efficiently, much like any other drug, while leveraging its core PA engine.

Related coverage

Other beovu prior authorization by payer

Other beovu prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo